Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion

The effects of indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019, or FFC14A), the second ruthenium compound that entered clinical trials, in an in vitro model of tumour invasion and metastasis show that the antitumour effects of this compound might include also the modulation of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergamo, A., Masi, A., Jakupec, M. A., Keppler, B. K., Sava, G.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2748298/
https://www.ncbi.nlm.nih.gov/pubmed/19789639
http://dx.doi.org/10.1155/2009/681270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2748298/
https://www.ncbi.nlm.nih.gov/pubmed/19789639
http://dx.doi.org/10.1155/2009/681270

Ejemplares similares